New Delhi:Sweden India Science Sambandhorganised a conference on ‘Dialogue on Medicine.which was scheduled on 21 November, 2020.’
Dr. Maneesh Paul, campus director for Acharya Institutes and chairperson for the SANI Bangalore chapter moderated the session with guest speakers Padma Bhushan awardee Professor (Dr.) Shiv Kumar Sarin and Professor (Dr.) Ola Weiland.
Padma Bhushan awardee Dr. Shiv Kumar Sarin’s statement that Hepatitis C will become a rare disease by 2035 was really assuring.
Dr.Sarin also emphasised on the impact of the work done by Harvey J. Alter, Michael Houghton and Charles M. Rice, which led to all three scientists winning the Nobel Prize Award 2020 in Medicine for the discovery of Hepatitis C virus.
Professor (Dr.) Ola Weiland, Senior Professor in Infectious Diseases at KarolinskaInstitutet and Senior Consultant at Karolinska University Hospital Huddinge, Sweden took us through an in depth journey of the discovery of Hepatitis C and dived into everything from molecular biology to clinical presentations and interventions.
Prof (Dr.) Ola stated that the Nobel Prize Award winner and American Virologist, Charles Moen Rice, provided the final evidence showing thatHepatitis C virus alone could cause hepatitis.
The Swedish India Science Sambandh is led by the Sweden Alumni Network India’s Mumbai chapter and co-organised by Developmatrix and the SANI chapters of Bangalore and Delhi with support from the Swedish Institute and Archarya Institutes. Sweden India Science Sambandh extends the Sweden India Sambandh to a month-long celebration of Science and Nobel awarded discoveries with activities including three dialogues in sciences and Women in STEM series addressing the gender gap in STEM. The aim of the program is to promote original thinking and imbibe a scientific culture among people, especially the young minds. The Nobel Prize being the most recognized name and connection to Sweden and often seen as the ultimate reward for a scientist.